Acelrx pharmaceuticals announces the appointment of jill broadfoot to its board of directors

Hayward, calif., nov. 23, 2021 /prnewswire/ -- acelrx pharmaceuticals, inc. (nasdaq: acrx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced the appointment of jill broadfoot to the company's board of directors.
ACRX Ratings Summary
ACRX Quant Ranking